2019 novel coronavirus

2019 novel coronavirus

March 11, 2022 阅读 582 评论 0 喜欢 0

We'll talk about this topic in early 2022.

Virus Pneumonia has been raging around the world for three years

It was first developed in Wuhan, China in 19 years

The emerging coronavirus covid-19 named the virus

As the name suggests, severe infectious pneumonia


Mutant virus branches

Alpha in the second half of 2020

Beta、Gamma、

Delta June 2020

Omicron (mutant up to 37)

Variant of Interest, VOI), as of July 2020 there were 7 plants

Lambda

Mu

December 2020 ~ November 2021

Symptoms of viral manifestations are persistently cyclical

That is, we can tell from the name that its harm is extremely harmful to the lungs!

Common symptoms of the disease include fever, cough, fatigue, shortness of breath, and loss of taste and smell. Similar to a cold with different symptoms!

1-14 days for virus observation time (half a month)

Means of detection

RT-PCR (Nucleic Acid Paper)

CRISPR (Test Paper)

Imaging diagnosis detection

實驗室檢測

Preventive means

Wash your hands frequently

Wear a mask (reduce secondary transmission from mouth foam)

Practice social distancing

Vaccination

cure

Uk taking for critically ill patients (corticosterol dexamethasone)

U.S. has adopted hydroxychloroquine and chloroquine (PDA to abolish) The U.S. Food and Drug Administration has approved the antiviral drug Veklury (remdesivir)

Plasma treatment

Vaccination

Countries' responses to Covid-19 vary widely from policy to response

Covid-19 special drugs

Monapi Lavemoleravir

S-217622 Clinical Phase I

Ambavir monoclonal antibody injection (BRII-196) and romizumab injection (BRII-198)

資料來源

https://www.twreporter.org/a/sars-cov-2-variants

https://zh.wikipedia.org/wiki/2019%E5%86%A0%E7%8A%B6%E7%97%85%E6%AF%92%E7%97%85

https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines

Leave a Reply

Your email address will not be published. Required fields are marked *

鲁ICP备19049325号

鲁公网安备 37142602000107号

© 2023 JSMSR